Piet Geusens Selected Research

Piet Geusens Research Topics

Disease

30	Osteoporosis 06/2022 - 04/2002
25	Rheumatoid Arthritis 01/2022 - 03/2002
11	Bone Resorption 10/2019 - 07/2005
8	Ankylosing Spondylitis 06/2020 - 10/2004
6	Psoriatic Arthritis 06/2020 - 08/2009
6	Inflammation (Inflammations) 01/2016 - 01/2011
6	Pain (Aches) 11/2010 - 08/2004
5	Multiple Sclerosis 02/2012 - 03/2002
5	Osteoarthritis 02/2011 - 08/2004
4	Infections 01/2020 - 04/2006
3	Osteoporotic Fractures 01/2020 - 06/2005
3	Osteitis Deformans (Paget's Disease of Bone) 03/2014 - 01/2009
3	Metabolic Bone Diseases (Osteopenia) 09/2011 - 09/2003
3	Postmenopausal Osteoporosis 03/2009 - 06/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2018
2	Candidiasis (Moniliasis) 01/2020 - 01/2018
2	Crohn Disease (Crohn's Disease) 01/2020 - 01/2018
2	Back Pain (Backache) 10/2019 - 01/2018
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 03/2015
2	Disease Progression 01/2018 - 01/2017
2	Arthritis (Polyarthritis) 01/2016 - 05/2007
2	Femoral Fractures (Femoral Fracture) 01/2014 - 11/2010
2	Vitamin D Deficiency 04/2010 - 08/2008
2	Autoimmune Diseases (Autoimmune Disease) 05/2007 - 09/2005
1	Cognitive Dysfunction 01/2022
1	Axial Spondyloarthritis 12/2020
1	Low Back Pain (Lumbago) 12/2020
1	Arthralgia (Joint Pain) 01/2018
1	Ulcerative Colitis 01/2018
1	Necrosis 01/2018
1	Joint Diseases (Joint Disease) 03/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2017
1	Knee Osteoarthritis 01/2017
1	Fatigue 12/2016
1	Chronic Disease (Chronic Diseases) 12/2016
1	Osteonecrosis (Kienbock's Disease) 05/2014

Drug/Important Bio-Agent (IBA)

11	GlucocorticoidsIBA 01/2022 - 08/2008
10	Pharmaceutical PreparationsIBA 01/2018 - 12/2005
9	Biomarkers (Surrogate Marker)IBA 12/2020 - 03/2007
9	Risedronic Acid (Actonel)FDA LinkGeneric 01/2020 - 01/2009
8	Teriparatide (Parathar)FDA Link 01/2020 - 09/2009
8	Diphosphonates (Bisphosphonates)IBA 01/2020 - 12/2005
7	Denosumab FDA Link 01/2022 - 01/2009
5	AntibodiesIBA 12/2020 - 08/2008
5	C-Reactive ProteinIBA 12/2020 - 02/2005
4	Peptides (Polypeptides)IBA 12/2020 - 02/2011
4	AutoantibodiesIBA 12/2020 - 02/2011
4	secukinumabIBA 01/2020 - 12/2016
4	CalciumIBA 01/2019 - 03/2002
4	Collagen Type I (Type I Collagen)IBA 01/2015 - 05/2004
4	MineralsIBA 01/2014 - 07/2005
4	CytokinesIBA 12/2012 - 03/2007
4	Infliximab (Remicade)FDA Link 09/2008 - 02/2005
3	romosozumabIBA 01/2022 - 01/2015
3	Monoclonal AntibodiesIBA 10/2019 - 01/2009
3	Antirheumatic Agents (DMARD)IBA 12/2017 - 02/2005
3	Methotrexate (Mexate)FDA LinkGeneric 03/2017 - 04/2014
3	Bone Density Conservation AgentsIBA 01/2015 - 11/2010
3	OsteoprotegerinIBA 08/2012 - 08/2004
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2007 - 03/2002
2	AutoantigensIBA 12/2020 - 02/2012
2	EnzymesIBA 12/2020 - 01/2015
2	golimumab FDA Link 06/2020 - 12/2017
2	Vitamin D FDA LinkGeneric 01/2019 - 12/2009
2	Biological ProductsIBA 12/2017 - 04/2014
2	Rheumatoid FactorIBA 01/2016 - 02/2011
2	odanacatibIBA 01/2015 - 05/2014
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 05/2014 - 06/2005
2	Zoledronic Acid (Zometa)FDA Link 05/2014 - 03/2014
2	LigandsIBA 08/2012 - 01/2009
2	RANK LigandIBA 08/2012 - 08/2004
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 06/2011 - 10/2004
2	Complementary DNA (cDNA)IBA 02/2011 - 08/2008
2	Selective Estrogen Receptor Modulators (SERM)IBA 12/2009 - 12/2005
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 12/2009 - 12/2005
2	strontium ranelate (protelos)IBA 12/2009 - 12/2005
2	Parathyroid Hormone (Parathormone)IBA 12/2009 - 12/2005
2	Naproxen (Naprosyn)FDA LinkGeneric 05/2009 - 04/2008
2	Analgesics (Analgesic Drugs)IBA 05/2009 - 04/2008
2	Procollagen Type IIBA 08/2008 - 07/2005
2	lumiracoxib (prexige)IBA 04/2008 - 08/2004
2	Messenger RNA (mRNA)IBA 09/2005 - 08/2004
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2022
1	ImmunosorbentsIBA 12/2020
1	Homeodomain Proteins (Proteins, Homeobox)IBA 12/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	GoldIBA 01/2018
1	Choline (Choline Chloride)IBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	AcidsIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Oxygen (Dioxygen)IBA 03/2015
1	Cathepsin KIBA 01/2015
1	blosozumabIBA 01/2015
1	Tumor Necrosis Factor InhibitorsIBA 04/2014

Therapy/Procedure

20	Therapeutics 06/2022 - 04/2002
3	Drug Therapy (Chemotherapy) 01/2013 - 08/2004
2	Duration of Therapy 03/2009 - 06/2005
1	Remission Induction 03/2017